Cover Image

THE ROLE OF MATRIX METALLOPROTEINASES IN PROCESSES OF HEART RE-MODELING IN CHILDREN WITH RESTRICTIVE CARDIOMYOPATHY

Show other versions (1)

Restrictive cardiomyopathy (RCMP) is heart disorder with unclear etiology; it can be characterized as disease with disorder of diastolic myocardium function of left ventricle, conditioned by restriction. The chronic heart failure as a syndrome of RCMP can develop as a result of disbalance in system...

Full description

Saved in:

Bibliographic Details
Main Authors:	T.V. Bershova (Author), A.G. Gasanov (Author), A.P. Ivanov (Author), E.V. Basargina (Author), M.I. Bakanov (Author), R.B. Zurabova (Author)
Format:	Book
Published:	"Paediatrician" Publishers LLC, 2009-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE ROLE OF MATRIX METALLOPROTEINASES IN PROCESSES OF HEART RE-MODELING IN CHILDREN WITH RESTRICTIVE CARDIOMYOPATHY
by: T.V. Bershova, et al.
Published: (2009)

STATE OF THE MATRIX METALLOPROTEINASES AND THEIR ROLE IN FORMATION OF THE CHRONIC HEART FAILURE IN CHILDREN WITH DILATED CARDIOMYOPATHY
by: E.N. Basargina, et al.
Published: (2009)

STATE OF THE MATRIX METALLOPROTEINASES AND THEIR ROLE IN FORMATION OF THE CHRONIC HEART FAILURE IN CHILDREN WITH DILATED CARDIOMYOPATHY
by: E.N. Basargina, et al.
Published: (2009)

DYNAMICS OF MATRIX METALLOPROTEINASE CONCENTRATION DURING THE TREATMENT OF CHILDREN WITH DILATED CARDIOMYOPATHY'S EARLY DEBUT
by: A.S. Gasanov, et al.
Published: (2011)

DYNAMICS OF MATRIX METALLOPROTEINASE CONCENTRATION DURING THE TREATMENT OF CHILDREN WITH DILATED CARDIOMYOPATHY'S EARLY DEBUT
by: A.S. Gasanov, et al.
Published: (2011)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017)

Matrix metalloproteinases and their inhibitors
by: O. S. Grigorkevich, et al.
Published: (2019)

Matrix Metalloproteinase
Published: (2020)

Matrix Metalloproteinases
by: S Sahitya, et al.
Published: (2010)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023)

Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2015)

DYNAMICS OF CARDIOVASCULAR SYSTEM PARAMETERS ON A BACKGROUND OF APPLICATION OF ADRENERGIC BLOCKERS IN CHILDREN WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
by: E.A. Tikhomirova, et al.
Published: (2007)

DYNAMICS OF CARDIOVASCULAR SYSTEM PARAMETERS ON A BACKGROUND OF APPLICATION OF ADRENERGIC BLOCKERS IN CHILDREN WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
by: E.A. Tikhomirova, et al.
Published: (2007)

Matrix metalloproteinases: the most important pathway involved with periodontal destruction
by: A.P De Souza, et al.
Published: (2015)

Clinico-histopathological study of varicose vein and role of matrix metalloproteinases-1, matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 in varicose vein formation
by: Bitan Naik, et al.
Published: (2016)

Matrix Metalloproteinases in Health and Disease
Published: (2020)

Expression of matrix metalloproteinases in diffuse gliomas: diagnostic value
by: T. V. Shynkarenko
Published: (2017)

Tissue inhibitor of matrix metalloproteinase-1 role in left atrium matrix remodeling in patients with atrial febrillation
by: A. V. Goryachiy, et al.
Published: (2017)

Tissue inhibitor of matrix metalloproteinase-1 role in left atrium matrix remodeling in patients with atrial febrillation
by: A. V. Goryachiy, et al.
Published: (2017)

Comparative characteristic of methods for determining the inflammation marker matrix metalloproteinase-9
by: E. V. Baranova, et al.
Published: (2014)

Variants of the <it>Matrix Metalloproteinase-2 </it>but not the <it>Matrix Metalloproteinase-9 </it>genes significantly influence functional outcome after stroke
by: Sobral João, et al.
Published: (2010)

Matrix Metalloproteinases and Hypertension-Mediated Organ Damage: Current Insights
by: Bisogni V, et al.
Published: (2020)

Matrix Metalloproteinases in patients with Multiple Sclerosis.
by: Rebeca A. Fernández Carriera, et al.
Published: (2007)

Matrix Metalloproteinases in patients with Multiple Sclerosis.
by: Rebeca A. Fernández Carriera, et al.
Published: (2007)

Pediatric Restrictive Cardiomyopathies
by: Raffaello Ditaranto, et al.
Published: (2022)

Matrix Metalloproteinase 2 as a Pharmacological Target in Heart Failure
by: Pricila Rodrigues Gonçalves, et al.
Published: (2022)

Clinical significance of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and 2 in Kawasaki disease
by: Ki Wook Yun, et al.
Published: (2010)

Role of matrix metalloproteinase 7 in ovarian cancer (review of literature)
by: R. I. Knyazev, et al.
Published: (2015)

Investigating salivary matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in fixed orthodontic-induced gingival enlargement
by: Narges Ziaei, et al.
Published: (2024)

The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors
by: Nabangshu Das, et al.
Published: (2020)

Role of Matrix Metalloproteinase-8 in Atherosclerosis
by: Sébastien Lenglet, et al.
Published: (2013)

Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection
by: Péter Bencsik, et al.
Published: (2018)

Prognostic value of determination of matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 in follicular fluid in patients in vitro fertilization programs
by: Olga A. Marinova, et al.
Published: (2021)

Restrictive Cardiomyopathy in a Child
by: Shan-Miao Lin, et al.
Published: (2008)

Matrix metalloproteinase-9 as an independent predictor of recurrence after catheter ablation of atrial fibrillation
by: A. V. Goryachiy, et al.
Published: (2017)

Matrix metalloproteinase-9 as an independent predictor of recurrence after catheter ablation of atrial fibrillation
by: A. V. Goryachiy, et al.
Published: (2017)

Expression of matrix metalloproteinase-2 in the extracellular matrix of osseointegrated and diseased implants
by: Ghada I Al-Duboni
Published: (2014)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014)

Chronic Cadmium Exposure Alters Cardiac Matrix Metalloproteinases in the Heart of Sprague-Dawley Rat
by: Sandra Concepcion Das, et al.
Published: (2021)

Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats
by: Dian Agustina Permatasari, et al.
Published: (2019)